News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imugene.
RELATED STOCKHEAD STORIES
News
ASX Small Caps Lunch Wrap: Who else feels like the wheels have come off this morning?
Health & Biotech
ASX Health Stocks: Patrys says brain cancer drug is effective; HitIQ awarded Aussie patent
News
ASX Large Caps: Investors flock to metal stocks on BHP-OZL news; benchmark finishes flat
News
ASX Small Caps Lunch Wrap: Who else has learnt that it’s lonely at the top?
News
ASX Small Caps Lunch Wrap: Who else reckons sequels are always a bad idea?
Health & Biotech
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs
News
ASX Small Caps Lunch Wrap: Who’s got someone coming round for lunch today?
Stockhead TV
V-Con: Small Cap Showcase – Companies set to perform and best bargains amidst turbulent market conditions
News
ASX Small Caps Lunch Wrap: Who else is hitting the creepy tech panic button today?
News
ASX Large Caps: All sectors in the green ahead of tomorrow’s rate hike
News
ASX Large Caps: Local shares flat, Aussie home prices accelerate descent
Health & Biotech
ScoPo’s Powerplays: ASX health stocks show signs of jittery recovery
News
ASX Small Caps Lunch Wrap: Who else is laughing at someone else’s expense today?
News
ASX Large Caps: Blue chips down for first time this week as Real Estate and Tech drag
News
ASX Small Caps Lunch Wrap: Who else is clutching their pearls today?
News
Closing Bell: ASX 200 rides the Wall Street wave, has its strongest lift in 6 weeks
News
